Importance of specimen length during temporal artery biopsy
暂无分享,去创建一个
A. Karthikesalingam | R. Ball | T. Tang | N. Chopra | E. Ypsilantis | E. Courtney | M. Eltayab | N. Katsoulas | T. Tang
[1] M. Walvick,et al. Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. , 2011, Ophthalmology.
[2] S. Walsh,et al. Role of ultrasonography in the diagnosis of temporal arteritis , 2010, The British journal of surgery.
[3] E. Eggenberger,et al. Diagnosis and management of giant cell arteritis: a review , 2010, Current opinion in ophthalmology.
[4] L. Brown,et al. An elastic Van Gieson stain is unnecessary for the histological diagnosis of giant cell temporal arteritis , 2010, Journal of Clinical Pathology.
[5] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.
[6] K. Barraclough,et al. BSR and BHPR guidelines for the management of giant cell arteritis. , 2010, Rheumatology.
[7] N. Newman,et al. Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases. , 2009, Ophthalmology.
[8] Peter McCluskey,et al. THE LENGTH OF SUPERFICIAL TEMPORAL ARTERY BIOPSIES , 2007, ANZ journal of surgery.
[9] L. Levin,et al. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. , 2007, Investigative ophthalmology & visual science.
[10] K. Arashvand. The value of temporal artery biopsy specimen length in the diagnosis of giant cell arteritis. , 2006, The Journal of rheumatology.
[11] J Coste,et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? , 2006, Annals of the rheumatic diseases.
[12] R. Taylor-Gjevre,et al. Temporal artery biopsy for giant cell arteritis. , 2005, The Journal of rheumatology.
[13] R. Foroozan,et al. Quantitative analysis of temporal artery contraction after biopsy for evaluation of giant cell arteritis. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[14] C. Weyand,et al. Pathogenic mechanisms in giant cell arteritis. , 2002, Cleveland Clinic journal of medicine.
[15] R. Tomsak. Giant cell arteritis. , 2002, Ophthalmology.
[16] W. Schmidt. Doppler ultrasonography in the diagnosis of giant cell arteritis. , 2000, Clinical and experimental rheumatology.
[17] P. Brazis,et al. Temporal Arteritis: A Clinical Approach , 1999, Journal of the American Geriatrics Society.
[18] A. Caroe. Temporal artery biopsy to diagnose temporal arteritis. , 1998, JAMA.
[19] L. Levin,et al. Visual loss in giant cell arteritis. , 1998, JAMA.
[20] C. Sudlow. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy. , 1997, BMJ.
[21] R. Sergott,et al. Giant cell arteritis. Corticosteroids, temporal artery biopsy, and blindness. , 1994, Archives of family medicine.
[22] W M O'Fallon,et al. How Does Previous Corticosteroid Treatment Affect the Biopsy Findings in Giant Cell (Temporal) Arteritis? , 1994, Annals of Internal Medicine.
[23] V. Kyle. Treatment of polymyalgia rheumatica/giant cell arteritis. , 1991, Bailliere's clinical rheumatology.
[24] R. Tomsak. Superficial temporal artery biopsy. A simplified technique. , 1991, Journal of clinical neuro-ophthalmology.
[25] P. Kearns. Use of hospital beds. , 1988, BMJ.
[26] B. Bengtsson,et al. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. , 1981, Arthritis and rheumatism.
[27] R. Klein,et al. Skip lesions in temporal arteritis. , 1976, Mayo Clinic proceedings.
[28] D GILMOUR,et al. Westergren and Wintrobe Methods of Estimating E.S.R. Compared* , 1951, British medical journal.
[29] R. Nesher,et al. Effect of biopsy length on the rate of positive temporal artery biopsies. , 2009, Clinical and experimental rheumatology.
[30] R. Kent,et al. Temporal artery biopsy. , 1990, The American surgeon.